Author

Josef Stolz

Institution: University Hospital in Motol

Observed institution: University Hospital in Motol

OpenAlex ID: A5111987059

A phase II study of 99mTc-trofolastat (MIP-1404) SPECT/CT to identify and localize prostate cancer in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) compared to histopathology: An interim analysis.

2014 · Kevin Mark Slawin, William J. Ellis, et al. · Journal of Clinical Oncology · 4

A phase 2 study of 99m Tc-trofolastat chloride (MIP-1404) SPECT/CT to identify and localize prostate cancer (PCa) in high-risk patients (pts) undergoing radical prostatectomy (RP) and extended pelvic lymph node (ePLN) dissection compared to histopathology: An interim analysis.

2014 · Kevin Mark Slawin, Peter Tenke, et al. · Journal of Clinical Oncology · 1

CODE 3) mRNA IN TISSUE OF PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA EXPRESE DD3 PCA3 (DIFFERENTIAL DISPLAY CODE 3) mRNA vE TkáNI PROSTATY U PACIENTů S kARCINOmEm PROSTATY A BENIGNí HYPERPLAzIí PROSTATY

2010 · Milan Hora, Viktor Eret, et al. · 1

Exprese DD3PCA3 (Differential Display Code 3) mRNA ve tkáni prostaty u pacientů s karcinomem prostaty a benigní hyperplazií prostaty

2010 · Jiří Klečka, Milan Hora, et al. · Česká urologie

Expresion of DD3PCA3 (Differential Display Code 3) mRNA in tissue of patients with prostate cancer and benign prostatic hyperplasia

2010 · Jiří Klečka, Milan Hora, et al. · Česká urologie

2nd annual European perspectives in urologic oncology, a case-based congress to enhance patient management

2008 · Viktor Soukup, Josef Stolz · Česká urologie

Works count: 6

Citation count: 6

H-index: 1

I10-index: